Live Breaking News & Updates on Friedrich Alexander University Erlangen N

Stay updated with breaking news from Friedrich alexander university erlangen n. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin. ....

Nordrhein Westfalen , Markus Eckstein Uniklinikum Erlangen , Uniklinikum Erlangen , Markus Eckstein , Department Of Urology , University Hospital Bonn , Institute Of Pathology , Hospital Bonn , Assistant Physician , Clinician Scientist , Friedrich Alexander University Erlangen N , Clinical Oncology , Antibody Drug Conjugate ,